Clinical Trial Result Information

Protocol number
PA18604

Title of Study
A Study of P38 Inhibitor (4) Monotherapy in Patients with Active Rheumatoid Arthritis

Sponsor
Hoffmann-La Roche

Company division
Pharmaceutical

Product name
P38 Inhibitor (4)

Therapeutic area
Rheumatoid Arthritis

Clinical study summary
No data will be posted since Roche made a strategic decision to terminate the project. The decision was based on failure to achieve the pre-specified efficacy endpoints of the study, and was not due to an unacceptable safety profile.

Phase of development
II

Date of report
5/2/2008

Click here for the protocol registry listing of this trial.